Last $15.71 USD
Change Today +0.41 / 2.68%
Volume 19.3K
As of 5:20 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

myos corp (MYOS) Key Developments

MYOS Corporation Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 09:00 AM

MYOS Corporation Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-12-2014 09:00 AM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States.

MYOS Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

MYOS Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the second quarter of 2014, the company's net sales were approximately $1,679,000 compared to net sales of approximately $715,000 for the second quarter of 2013 and approximately $1,546,000 for the first quarter of 2014. Loss from operations was approximately $1,001,000 compared to approximately $985,000 for the second quarter of 2013 and approximately $423,000 for the first quarter of 2014. Net loss was approximately $1,000,000 compared to approximately $984,000 for the second quarter of 2013 and approximately $422,000 for the first quarter of 2014. Basic and diluted net loss per share was $0.34 compared to $0.44 for the second quarter of 2013 and $0.16 for the first quarter of 2014. Non-GAAP, net loss was approximately $523,000 compared to approximately $608,000 for the second quarter of 2013. Non-GAAP basic and diluted net loss per share was $0.18 compared to $0.27 for the second quarter of 2013 and $0.04 for the first quarter of 2014. For the six months, the company reported net loss of $1,422,000 or $0.51 per basic and diluted share on revenue of $3,225,000 compared to net loss of $2,074 or $0.94 per basic and diluted share on revenue of $993,000 reported a year ago. Operating loss was $1,424,000 compared to $2,077,000 for the same period last year. Non-GAAP - net loss was $642,000 compared to $1,336,000 for the same period last year. Non-GAAP basic and diluted net loss per share was $0.23 compared to $0.61 for the same period last year.

MYOS Corporation to Report Q2, 2014 Results on Aug 14, 2014

MYOS Corporation announced that they will report Q2, 2014 results Pre-Market on Aug 14, 2014

MYOS Corporation, Q2 2014 Earnings Call, Aug 14, 2014

MYOS Corporation, Q2 2014 Earnings Call, Aug 14, 2014

MYOS Corporation Announces Appointment of Douglas Weekes as Chief Commercial Officer

MYOS Corporation announced that it has appointed Douglas Weekes as Chief Commercial Officer. Mr. Weekes will lead the company's marketing, sales and product development of a portfolio of commercial products derived from the first clinically proven natural myostatin inhibitor, Fortetropin(TM). Mr. Weekes will lead the creation of several bionutrition products including bars, meal replacement formats and ready to drink beverages utilizing Fortetropin. Mr. Weekes is a 20-year veteran of the consumer products industry having led successful business units across the Beverages, Personal Care and Nutrition/Energy bar categories at Kraft Foods Group, and Henkel KGaA, most recently as Vice President and General Manager of the Refreshment Beverages unit. His experience includes creating and growing new products and brands, as well as managing large portfolios of household name brands.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYOS:US $15.71 USD +0.41

MYOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MYOS.
View Industry Companies
 

Industry Analysis

MYOS

Industry Average

Valuation MYOS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.0x
Price/Book 6.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYOS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.